Dark Light

Iboga TA/Buy Iboga TA Australia


Iboga TA

Physical property: 

Brown powder

Main ingredient:

iboga root bark



Iboga TA/Buy Iboga TA Australia

—- What is Iboga TA —-

Iboga TA/Buy Iboga TA Australia . The term iboga (sometimes spelled eboga or eboka) refers to a small variety of African plant species in the Apocynaceae family, principally Tabernanthe iboga and T. manii.1 There are at least seven identified species in Gabon alone, although variations are not always botanically distinguished.

These unassuming perennial shrubs are endemic to equatorial West Africa, where they grow in the jungle understory in a region encompassing the borders of Gabon, Cameroon, Angola, and the Republic of the Congo (Congo-Brazzaville).1 Mature plants are typically one to two meters (3.3 to 6.6 feet) in height but can grow up to ten meters (32.8 feet) under certain circumstances, and they produce inedible, oblong orange fruits after their first year. Iboga TA/Buy Iboga TA Australia

Iboga has been translated as “to care for” or “to heal” in various tribal dialects* of the Congo Basin where it plays an important cultural role, especially in Gabon. There, it has been used for centuries as a medicine and sacrament, particularly in the traditional spiritual discipline of Bwiti.

The plant’s medicinal alkaloids are concentrated in the inner layer of its extremely bitter bark, which is peeled from the roots of mature plants — at least three to five years of age, although older plants are preferred when available. The harvesting process often involves uprooting the entire shrub, but there are more time-consuming methods of harvesting root bark from living plants that allow the plant to regenerate but stunt further growth. Iboga TA/Buy Iboga TA Australia

—- What is iboga TA good for ? —-

Conditions in which is used:

people use iboga for withdrawal from heroin, morphine, and other opioids, as well as for fever, addictions, and many other conditions, but there is no good scientific evidence to support any use. Using iboga can also be unsafe. Iboga TA/Buy Iboga TA Australia

• People take iboga power in case of Addictions
• In case of Depression
• Drowsiness
• High Fever
• The Flu, swine flu
• High blood pressure
• Any Nerve Disorder
• Fatigue
• Low sex drive
• They can use it to increase sex drive, a general tonic to prevent addiction.

— Is Iboga TA an hallucinogenic? —- Iboga TA/Buy Iboga TA Australia

ibogaine, hallucinogenic drug and the principal iboga alkaloid, found in the stems, leaves, and especially in the roots of the African shrub Tabernanthe iboga. Ibogaine was isolated from the plant in 1901 and was synthesized in 1966. In small doses it acts as a stimulant.

— What is Iboga TA made of? —

Ibogaine is the main active ingredient of Tabernanthe iboga, a West African shrub that grows in the Congo and Angola,233 and is isolated from the root bark. It has been used traditionally as a hallucinogen, to suppress hunger and fatigue, and as an aphrodisiac. Iboga TA/Buy Iboga TA Australia

— What does Iboga TA do to the brain? —-

Ibogaine Administration Modifies GDNF and BDNF Expression in Brain Regions Involved in Mesocorticolimbic and Nigral Dopaminergic Circuits. Ibogaine is an atypical psychedelic alkaloid, which has been subject of research due to its reported ability to attenuate drug-seeking behaviour.

—- Iboga TA treatment —

Ibogaine is a naturally occurring psychoactive substance found in plants in the family Apocynaceae such as Tabernanthe iboga, Voacanga africana, and Tabernaemontana undulata. It is a psychedelic with dissociative properties. Preliminary research indicates that it may help counter drug addiction.

—– Legality of Iboga TA ——

Despite the potential healing benefits of ibogaine, its legal status varies from country to country. In some cases due to its hallucinogenic properties, and in some cases due to its heart risks, it is prohibited to varying degrees in some places.
Although illegal in the United States, iboga can be consumed with relative freedom in the City of Oakland, CA. On June 4, 2019, the city council voted unanimously to decriminalize all “entheogenic plants” containing indoleamines, tryptamines, and phenethylamines.

This allows adults aged 21 years and older to use them either medicinally (in accordance with the resolution’s official intent) or for any other reason without fear of criminal punishment. It also specifically decriminalizes (or rather deprioritizes for law enforcement) their cultivation and distribution.

Ibogaine is also legal to possess and distribute in Brazil, Mexico, South Africa, Gabon, New Zealand, the Netherlands, and Costa Rica. Treatment canters exist in most of these countries.

For a full guide to the legality of ibogaine worldwide

— Iboga TA effects —- Iboga TA/Buy Iboga TA Australia

Ibogaine, a chemical in iboga, is POSSIBLY SAFE when taken by mouth in smaller doses and under a health care professionals supervision. Due to potentially dangerous side effects it should not be used without advice of a medical practitioner.

Ibogaine POSSIBLY UNSAFE when taken by mouth in large doses. Ibogaine might cause an irregular heartbeat, thinking disturbances, heart attack, and death.

Ibogaine can cause other side effects such as low blood pressure, slow heart rate, seizures, paralysis, difficulty breathing, anxiety, hallucinations and death.

There isn’t enough information to know if iboga the shrub is safe to be used.

—- iboga dosage —–

Strict medical supervision is necessary. Maximum blood levels and elimination half-life of ibogaine vary among individuals. Due to documented toxicity, ibogaine should be used only under supervision of a health care provider experienced in its use.

The authors of a review of clinical trial and toxicology data recommend a maximum oral dosage limit of less than 1 mg/kg as an initial dose in the treatment of drug dependence, which can then be increased incrementally, to avoid potentially life-threatening adverse effects.

A single dose of ibogaine 500 to 800 mg has been used in clinical trials for the treatment of opioid addiction; dividing the dose and administering smaller doses over several days or weeks has been suggested as a safer alternative.

An average single dose of 17 mg/kg has been used in a Brazilian clinic in combination with psychotherapy under close medical supervision with second, third, and fourth single-dose sessions provided at mean-time intervals of 245 days (±226 days), 303 days (±278 days), and 112 days (±100 days), respectively

—- USES & EFFECTIVENESS of Iboga —- Iboga TA/Buy Iboga TA Australia

Insufficient Evidence to Rate Effectiveness for…
Drug abuse. Early evidence suggests that ibogaine, a chemical in iboga, can help increase abstinence and relieve withdrawal symptoms in people abusing drugs such as heroin, codeine, cocaine and other substances such as alcohol, tobacco, and marijuana. However the existing research is flawed and unreliable.
High blood pressure.
Nerve disorders.
Preventing fatigue and drowsiness.
Other conditions.

—- Toxicology of Iboga TA —-

Large doses of iboga can induce agitation, hallucinations, vomiting, ataxia, muscle spasms, weakness, seizures, paralysis, arrhythmias, urinary retention, respiratory insufficiency, and cardiac arrest. Iboga TA/Buy Iboga TA Australia

—- Can Iboga be used when pregnant ? —-

Avoid use. Information regarding the safety and efficacy in pregnancy and lactation is lacking.

—- Iboga TA/Buy Iboga TA Australia —–


—- Psychological Symptoms of Iboga —–

As a psychedelic drug with both classic hallucinogen and dissociative properties, ibogaine has potent psychological symptoms. Most of these occur during the “trip,” but there are risks of permanent or long-lasting psychological adverse effects.

Psychological symptoms that are characteristic of an ibogaine trip can include:

Psychosis (loss of touch with reality, inability to think logically)
Paranoia (a type of psychosis)
Feelings of relaxation
Perceived spiritual experiences
Bizarre behaviour

Other Ibogaine Side Effects

The most feared adverse effect of ibogaine is death. There have been more than 30 documented cases of death attributed to ibogaine use, but the actual number of ibogaine-related deaths is likely much higher since it is an illegal drug and therefore used secretly, often alone. It is possible that death from ibogaine use may be mistaken for a drug overdose related to a different substance.

One recent death from ibogaine in the U.S. was well documented in a case study. In this case, a 40-year-old man had self-administered 4g of ibogaine and an unidentified “booster” that he bought off the internet. Eight hours later he was found unresponsive, covered in vomit and in shock. He was rushed to the hospital, but he was in cardiac arrest and his brain had swollen to the point of being brain dead. The decision was made to remove him from life support.

This was not an isolated case, as ibogaine and other related compounds from the iboga plant are known to be toxic to the heart.

Ibogaine can cause persistent, long-term side effects, even after using it only once or a few times. These side effects include:

Speech impairment
Weight loss
Memory problems
Mental health disorders (especially anxiety, depression, and suicidality)
Persistent psychosis

Hallucinogen persisting perception disorder (HPPD): recurrences of drug “trips” without taking the drug
Since ibogaine is illegal, it is produced in unregulated labs and is not subjected to the standards and oversight of the FDA. Therefore, the actual content and amount of active ingredients and the presence of impurities are uncertain in any preparation of the drug. Side effects can, therefore, be unpredictable.

—– Adverse Reactions of Iboga Powder —-

Anecdotal reports indicate that ibogaine slows heart rate. This effect has been observed in awake and free-moving rats in which high intraperitoneal doses (100 and 200 mg/kg) decreased heart rate without altering blood pressure. Single doses of ibogaine have been well tolerated in clinical studies with no clinically important adverse effects reported.  The most frequently observed effects included ataxia, mild tremor, and nausea soon after drug administration.

Hypotension occurred in some cocaine-dependent patients, but responded to volume repletion. Manic episodes lasting 1 to 2 weeks have also been reported in a few cases, manifested as sleeplessness, irritability, impulsivity, emotional lability, grandiose delusions, rapid tangential speech and aggressive behaviour, and suicidal ideation.

Fatalities have been associated with the use of ibogaine; concomitant opioid use and comorbidities (eg, cardiovascular disease, depression, posttraumatic stress disorder, anxiety, stress, schizophrenia, epilepsy, or other imbalances in the autonomic nervous system) increase the risk of life-threatening complications including sudden cardiac death

— Ibogaine success rate — Iboga TA/Buy Iboga TA Australia

Due to its status as a Schedule I drug, ibogaine has primarily been used as a treatment for addiction in non-traditional clinical settings outside of the United States. Statistics on its efficacy, therefore, are somewhat difficult to come by.

Two studies conducted by MAPS in Mexico and New Zealand found significant long-term reduction of withdrawal symptoms in 20% and 50% of participants, respectively.

Another recent study in Brazil found that a combination of ibogaine and psychotherapy led to the long-term reduction of symptoms in over 60% of participants, highlighting ibogaine’s potential as a supplementary tool in overcoming addiction.

A recent observational study of people with chronic addiction from the Johns Hopkins School of Medicine also suggests that ibogaine treatment can significantly improve opioid abstinence. Of 88 subjects interviewed, 80% reported that ibogaine either drastically reduced or totally abated their withdrawal symptoms, with 30% abstaining from opioid use for years following the treatment. Iboga TA/Buy Iboga TA Australia

In combination with social support and a structured treatment plan that focuses on long-term goals, ibogaine is showing tremendous promise in treating addiction.


10g, 20g, 50g, 5g

You cannot copy content of this page